Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Dr Reddy's completes acquisition of 8 Teva ANDAs - The Hindu BusinessLine
What GSK v. Teva Means for ANDA Skinny Labels
Evoke Announces Teva Ends Pursuit of Paragraph IV ANDA
Teva Pharmaceutical Industries (NYSE: TEVA) Q4 2019 Earnings | AlphaStreet
Rosiglitazone Maleate and Glimepiride Tablets, 4 mg (base)/1 mg, 4 mg (base)/2 mg, 4 mg (base)/4 mg, 8 mg (base)/2 mg, and 8 mg
Who We Are | AndaNet
Allergan sells Anda to Teva for $500 million - CDR – Chain Drug Review
Who We Are | AndaNet
San Francisco reaches $58 mln opioid settlement with Teva, Allergan | Reuters
FDA Approval Letter - Teva Pharmaceuticals
Teva brochure for Institutional Medicine Sales | Behance
Anda - Crunchbase Company Profile & Funding
Teva Holds off Huntington's Competitor, Resolves Opioid Cases | BioSpace
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
New York State Jury Finds Manufacturer Teva and Distributor Anda Liable for Fueling Opioid Epidemic in New York State - Simmons Hanly Conroy
Teva: Dr. Reddy's buys eight ANDAs from Teva for $350 million - The Economic Times
Teva to Buy Generics Distributor Anda From Allergan for $500 Million - WSJ
Generics distributor Anda, Inc. has a new owner: Teva Pharma
Teva Pharmaceuticals USA and Anda, Inc.... - Kids In Distress | Facebook
Teva to Buy Anda from Allergan | CHEManager
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva to pay New York $500M for role in opioid crisis - POLITICO
New York Opioid Trial: Allergan Settlement Leaves Teva as Last Target - Bloomberg
